Amedeo's Top 20

Amedeo Smart

Independent Medical Education

01 January 2020

Multidisciplinary Journal Club

  1. Cuzick J, Sestak I, Forbes JF, Dowsett M, et al.
    Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.
    Lancet 2019.

  1. Butler J, Packer M, Greene SJ, Fiuzat M, et al.
    Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues.
    Circulation 2019;140:2108-2118.

  2. Leucht S, Crippa A, Siafis S, Patel MX, et al.
    Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
    Am J Psychiatry 2019.

  3. D'Amico G, Abraldes JG, Rebora P, Valsecchi MG, et al.
    Ordinal Outcomes Are Superior to Binary Outcomes for Designing and Evaluating Clinical Trials in Compensated Cirrhosis.
    Hepatology 2019.

  4. Wijers JNAP, Dukers-Muijrers NHTM, van Liere GAFS, Dirks JAMC, et al.
    Men and women have an equal oropharyngeal and anorectal Chlamydia trachomatis bacterial load: a comparison of three anatomic sites.
    J Infect Dis 2019.

  1. Bradley JD, Hu C, Komaki RR, Masters GA, et al.
    Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
    J Clin Oncol 2019.

  2. Carson JAS, Lichtenstein AH, Anderson CAM, Appel LJ, et al.
    Dietary Cholesterol and Cardiovascular Risk: A Science Advisory From the American Heart Association.
    Circulation 2019.

  3. Lee SY, Cabral HJ, Aschengrau A, Pearce EN, et al.
    Associations between Maternal Thyroid Function in Pregnancy and Obstetric and Perinatal Outcomes.
    J Clin Endocrinol Metab 2019.

  4. Afifi AM, Saad AM, Al-Husseini MJ, Elmehrath AO, et al.
    Causes of death after breast cancer diagnosis: A US population-based analysis.
    Cancer 2019.

  5. Dickinson D, Zaidman SR, Giangrande EJ, Eisenberg DP, et al.
    Distinct Polygenic Score Profiles in Schizophrenia Subgroups With Different Trajectories of Cognitive Development.
    Am J Psychiatry 2019.

  1. Rainteau N, Salesse RN, Macgregor A, Macioce V, et al.
    Why you can't be in sync with schizophrenia patients.
    Schizophr Res 2019.

  2. Schmid P, Abraham J, Chan S, Wheatley D, et al.
    Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.
    J Clin Oncol 2019.

  3. Zhang D, Nichols HB, Troester M, Cai J, et al.
    Tea consumption and breast cancer risk in a cohort of women with family history of breast cancer.
    Int J Cancer 2019.

  4. Tang W, Mao J, Li KT, Walker JS, et al.
    Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis.
    Sex Transm Infect 2019.

  5. Blokzijl F, Houterman S, van Straten BHM, Daeter E, et al.
    The impact of surgical aortic valve replacement on quality of life-a multicenter study.
    J Thorac Cardiovasc Surg 2019.

  1. Wissing KM, Francois K, Pipeleers L.
    Improving outcomes after renal transplantation starts well before surgery - the role of renal replacement modality.
    Transpl Int 2019.

  2. Martins F, Schiappacasse L, Levivier M, Tuleasca C, et al.
    The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
    J Neurooncol 2019.

  3. Fani L, Hilal S, Sedaghat S, Broer L, et al.
    Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study.
    J Alzheimers Dis 2019.

  4. Zhang T, Wilson IB, Youn B, Lee Y, et al.
    Factors Associated with ART Re-Initiation in Medicaid Recipients with HIV.
    J Infect Dis 2019.

  5. Beau-Faller M, Pencreach E, Leduc C, Blons H, et al.
    Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF%2
    Lung Cancer 2019;140:19-26.


more..

Privacy Policy